About this data
What it is
An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
Who files it
The investor, within days of crossing 5%, and again whenever the stake changes materially.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.

All of this comes from public filings.

Filings per day, last 30 days

0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0
0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0

13D (activist) 13G (passive)

Latest ownership filings

Reset

Showing: ticker PKBK

Latest ownership filings
FiledScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders.CompanyInvestorShares% of sharesFiling
Aug 14, 2026SCHEDULE 13G/A (amended)PKBK
Parke Bancorp, Inc.
L. Phillip Stone, IV1000.0%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)PKBK
Parke Bancorp, Inc.
Fourthstone Small-Cap Financials Fund LP00.0%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)PKBK
Parke Bancorp, Inc.
Fourthstone QP Opportunity Fund LP210.0%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)PKBK
Parke Bancorp, Inc.
Fourthstone GP LLC210.0%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)PKBK
Parke Bancorp, Inc.
Fourthstone Master Opportunity Fund Ltd790.0%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)PKBK
Parke Bancorp, Inc.
Fourthstone LLC1000.0%SCHEDULE 13G/A ↗
Apr 9, 2026SCHEDULE 13GPKBK
Parke Bancorp, Inc.
Dimensional Fund Advisors LP599,2095.1%SCHEDULE 13G ↗
Feb 13, 2026SCHEDULE 13GPKBK
Parke Bancorp, Inc.
L. Phillip Stone, IV620,8995.3%SCHEDULE 13G ↗
Feb 13, 2026SCHEDULE 13GPKBK
Parke Bancorp, Inc.
Fourthstone Small-Cap Financials Fund LP1,8580.0%SCHEDULE 13G ↗
Feb 13, 2026SCHEDULE 13GPKBK
Parke Bancorp, Inc.
Fourthstone QP Opportunity Fund LP128,6191.1%SCHEDULE 13G ↗
Feb 13, 2026SCHEDULE 13GPKBK
Parke Bancorp, Inc.
Fourthstone GP LLC130,4771.1%SCHEDULE 13G ↗
Feb 13, 2026SCHEDULE 13GPKBK
Parke Bancorp, Inc.
Fourthstone Master Opportunity Fund Ltd490,4224.2%SCHEDULE 13G ↗
Feb 13, 2026SCHEDULE 13GPKBK
Parke Bancorp, Inc.
Fourthstone LLC620,8995.3%SCHEDULE 13G ↗
Sep 9, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
RPS Master - Investment Management RPS 2014 LP540,1034.6%SCHEDULE 13D/A ↗
Sep 9, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
Ron Shemer557,4534.7%SCHEDULE 13D/A ↗
Sep 9, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
Alphabeta Ai Multi Strategy, LP8,9500.1%SCHEDULE 13D/A ↗
Sep 9, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
Jacob Shemer549,0534.6%SCHEDULE 13D/A ↗
Aug 27, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
RPS Master - Investment Management RPS 2014 LP591,0835.0%SCHEDULE 13D/A ↗
Aug 27, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
Ron Shemer611,7935.2%SCHEDULE 13D/A ↗
Aug 27, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
Alphabeta Ai Multi Strategy, LP12,3100.1%SCHEDULE 13D/A ↗
Aug 27, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
Jacob Shemer603,3935.1%SCHEDULE 13D/A ↗
Aug 6, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
RPS Master - Investment Management RPS 2014 LP742,9836.3%SCHEDULE 13D/A ↗
Aug 6, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
Ron Shemer768,4686.5%SCHEDULE 13D/A ↗
Aug 6, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
Alphabeta Ai Multi Strategy, LP17,0851.0%SCHEDULE 13D/A ↗
Aug 6, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
Jacob Shemer760,0686.4%SCHEDULE 13D/A ↗
Feb 28, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
RPS Master - Investment Management RPS 2014 LP809,0116.8%SCHEDULE 13D/A ↗
Feb 28, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
Ron Shemer832,7037.0%SCHEDULE 13D/A ↗
Feb 28, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
Alphabeta Ai Multi Strategy, LP15,2920.0%SCHEDULE 13D/A ↗
Feb 28, 2025SCHEDULE 13D/A (amended)PKBK
Parke Bancorp, Inc.
Jacob Shemer824,3036.9%SCHEDULE 13D/A ↗

29 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:06 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances